(Q46479045)

English

Same drug, different dosing: differences in dosing for drugs approved in the United States, Europe, and Japan

scientific article published on 4 June 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

Same drug, different dosing: differences in dosing for drugs approved in the United States, Europe, and Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

author name string

Henry J Malinowski

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

Agnes Westelinck

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

Junko Sato

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

Ting Ong

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

publication date

4 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

48

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

8

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

900-908

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980-1999.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319794

21 January 2018

Troglitazone: the lesson that nobody learned?

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319794

21 January 2018

Withdrawal of cerivastatin from the world market

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319794

21 January 2018

Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.

1 reference

https://api.crossref.org/works/10.1177%2F0091270008319794

21 January 2018

Identifiers

10.1177/0091270008319794

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18524997

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46479045&oldid=2113382317"